UBS Group AG - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$190,473,820
+1.7%
1,869,957
+0.7%
0.06%
+3.2%
Q2 2023$187,344,561
+8.0%
1,856,551
-1.5%
0.06%0.0%
Q1 2023$173,427,544
-8.4%
1,885,082
-9.6%
0.06%
-11.3%
Q4 2022$189,259,429
+6.2%
2,086,193
-11.0%
0.07%
-9.0%
Q3 2022$178,222,000
-19.1%
2,344,723
-10.1%
0.08%
-13.3%
Q2 2022$220,360,000
-21.0%
2,606,888
-18.0%
0.09%
-3.2%
Q1 2022$278,807,000
-25.2%
3,177,281
-25.4%
0.09%
-13.1%
Q4 2021$372,779,000
+1.0%
4,261,800
-5.6%
0.11%
-7.8%
Q3 2021$369,015,000
-15.1%
4,512,279
-5.2%
0.12%
-17.1%
Q2 2021$434,479,000
+1.0%
4,761,936
-5.4%
0.14%
-2.1%
Q1 2021$430,210,000
-17.6%
5,032,866
-8.9%
0.14%
-18.8%
Q4 2020$521,787,000
-9.8%
5,525,651
-17.0%
0.18%
-19.3%
Q3 2020$578,649,000
-1.9%
6,654,204
-1.5%
0.22%
-12.4%
Q2 2020$589,740,000
-3.5%
6,752,233
-8.9%
0.25%
-13.5%
Q1 2020$611,083,000
-20.2%
7,411,564
-8.3%
0.29%
+8.3%
Q4 2019$765,598,000
+15.6%
8,085,307
+6.1%
0.27%
+4.3%
Q3 2019$662,024,000
-7.4%
7,618,234
-2.7%
0.26%
-7.3%
Q2 2019$714,909,000
+4.8%
7,829,477
+10.4%
0.28%
-2.5%
Q1 2019$682,076,000
+16.0%
7,094,603
+3.6%
0.28%
+6.0%
Q4 2018$587,914,000
+1.8%
6,851,347
+2.2%
0.27%
+16.2%
Q3 2018$577,730,000
+16.3%
6,705,320
+2.0%
0.23%
+6.5%
Q2 2018$496,654,000
-5.9%
6,574,716
+0.7%
0.22%
-5.7%
Q1 2018$527,827,000
+0.1%
6,528,477
+3.9%
0.23%
+5.1%
Q4 2017$527,446,000
-0.1%
6,282,109
+2.1%
0.22%
-11.1%
Q3 2017$528,036,000
+1.8%
6,151,227
-1.1%
0.24%
-9.0%
Q2 2017$518,941,000
+16.5%
6,217,111
+3.7%
0.27%
+10.3%
Q1 2017$445,464,000
+8.6%
5,997,901
+6.5%
0.24%
+7.0%
Q4 2016$410,238,000
-6.3%
5,632,031
+1.5%
0.23%
-13.0%
Q3 2016$437,952,000
-2.2%
5,546,496
+2.2%
0.26%
-7.1%
Q2 2016$448,007,000
+18.7%
5,429,711
+4.2%
0.28%
+11.1%
Q1 2016$377,526,000
-10.6%
5,211,565
+6.2%
0.25%
-7.7%
Q4 2015$422,361,000
-7.8%
4,908,904
-1.5%
0.27%
-15.4%
Q3 2015$458,160,000
-9.2%
4,984,352
-2.9%
0.32%
-3.3%
Q2 2015$504,792,000
+1.4%
5,133,127
+1.6%
0.34%
-2.6%
Q1 2015$498,007,000
+9.6%
5,050,270
+3.0%
0.34%
+8.2%
Q4 2014$454,205,0004,901,8400.32%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders